Mouse eosinophils possess potent antibacterial properties in vivo.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2772534)

Published in Infect Immun on August 24, 2009

Authors

Stefanie N Linch1, Ann M Kelly, Erin T Danielson, Ralph Pero, James J Lee, Jeffrey A Gold

Author Affiliations

1: Oregon Health and Science University, Division of Pulmonary and Critical Care Medicine, 3181 SW Sam Jackson Park Rd., Mail Code UHN67, Portland, OR 97239, USA.

Articles citing this

Eosinophils: changing perspectives in health and disease. Nat Rev Immunol (2012) 2.69

The expanding role(s) of eosinophils in health and disease. Blood (2012) 1.35

Eosinophils in innate immunity: an evolving story. Cell Tissue Res (2010) 1.34

What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol (2010) 1.33

Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice. Infect Immun (2011) 1.14

The expanding world of extracellular traps: not only neutrophils but much more. Front Immunol (2013) 1.12

Pattern-recognition receptors in human eosinophils. Immunology (2012) 1.00

Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am J Respir Crit Care Med (2012) 1.00

Eosinophils in mucosal immune responses. Mucosal Immunol (2015) 0.97

Eosinophil secretion of granule-derived cytokines. Front Immunol (2014) 0.95

Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol (2011) 0.93

Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol (2013) 0.92

Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol (2014) 0.91

Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? J Innate Immun (2011) 0.90

Eosinophil deficiency compromises lung defense against Aspergillus fumigatus. Infect Immun (2013) 0.89

Neutrophil extracellular traps as innate immune reaction against the emerging apicomplexan parasite Besnoitia besnoiti. PLoS One (2014) 0.87

Human Blood-Circulating Basophils Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells. J Virol (2015) 0.83

Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.83

Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis. Infect Immun (2013) 0.82

Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner. Infect Immun (2014) 0.82

Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation. PLoS One (2012) 0.78

The presence of eosinophil leucocytes in cervicovaginal smears with Actinomyces-like organisms: Light microscopic examination. J Cytol (2012) 0.76

Articles cited by this

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58

The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30

The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67

The immunopathogenesis of sepsis. Nature (2002) 11.83

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51

Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 4.93

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet (2000) 4.81

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet (1998) 4.05

Cecal ligation and puncture. Shock (2005) 3.93

Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care (2007) 3.80

Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30

High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17

Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med (2008) 2.11

A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med (2002) 2.05

Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med (1998) 1.86

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock (1995) 1.84

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82

Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80

Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest (2005) 1.77

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med (1996) 1.73

Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol (2003) 1.72

G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood (2007) 1.66

Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64

Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol (2001) 1.62

Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood (2007) 1.52

Neutrophil dysfunction and increased susceptibility to infection. Eur J Clin Invest (1995) 1.45

Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care (2008) 1.44

Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med (1996) 1.40

Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol (2006) 1.31

Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol (2007) 1.26

Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24

Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae. Infect Immun (1984) 1.24

Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol (1995) 1.21

Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest (1975) 1.20

CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun (2003) 1.15

Utility of eosinophil count as predictor of bacteremia. Clin Infect Dis (2004) 1.12

The inflammatory balance in human sepsis. Intensive Care Med (2000) 1.08

Markers of inflammation in sepsis. Ann Med (2002) 1.06

Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial. Arch Surg (2006) 1.02

Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol (1998) 0.98

Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun (2003) 0.96

Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. Microbes Infect (2005) 0.93

Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol (2005) 0.93

Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect Immun (2001) 0.92

Circulating blood eosinophils in acute infectious disease and the eosinopenic response. Am J Med (1952) 0.89

The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood (1998) 0.89

Allergic airway inflammation and susceptibility to pneumococcal pneumonia in a murine model with real-time in vivo evaluation. Clin Exp Immunol (2009) 0.89

Septic plasma suppresses superoxide anion synthesis by normal homologous polymorphonuclear leukocytes. Crit Care Med (1989) 0.87

Congenital disorders of the function of polymorphonuclear neutrophils. Rev Infect Dis (1980) 0.87

Regulation of neutrophil superoxide production in sepsis. Arch Surg (1985) 0.86

Monocyte deactivation in septic shock. Curr Opin Infect Dis (1998) 0.79

Articles by these authors

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08

Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 4.93

Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (2009) 4.92

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol (2011) 2.83

A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem (2002) 2.34

Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med (2008) 2.11

Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol (2006) 2.06

The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut (2012) 1.98

A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2009) 1.85

Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice. Blood (2013) 1.72

Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol (2007) 1.67

A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol (2003) 1.65

Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol (2004) 1.62

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol (2006) 1.56

Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol (2007) 1.55

Activated mouse eosinophils protect against lethal respiratory virus infection. Blood (2013) 1.54

Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun (2006) 1.53

Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes. J Clin Oncol (2007) 1.50

Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol (2012) 1.50

A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol (2004) 1.49

Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood (2006) 1.42

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer. J Clin Oncol (2005) 1.41

Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother (2007) 1.39

CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med (2007) 1.37

The expanding role(s) of eosinophils in health and disease. Blood (2012) 1.35

Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol (2008) 1.33

Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol (2009) 1.30

Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice. Infect Immun (2006) 1.29

Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol (2005) 1.28

Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis (2007) 1.25

Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J Allergy Clin Immunol (2006) 1.24

In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J Leukoc Biol (2002) 1.23

Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol (2011) 1.22

The logic of indirect speech. Proc Natl Acad Sci U S A (2008) 1.21

Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am J Physiol Lung Cell Mol Physiol (2002) 1.20

Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G). Genomics (2003) 1.18

Galphai2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation. Proc Natl Acad Sci U S A (2007) 1.18

Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One (2009) 1.17

Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res (2013) 1.16

Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice. Infect Immun (2011) 1.14

Eosinophils and asthma. Curr Allergy Asthma Rep (2007) 1.14

T(H)2-mediated pulmonary inflammation leads to the differential expression of ribonuclease genes by alveolar macrophages. Am J Respir Cell Mol Biol (2002) 1.12

Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol (2012) 1.12

The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease. J Immunol Methods (2011) 1.12

Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscul Disord (2004) 1.11

Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect Immun (2006) 1.11

Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol (2004) 1.11

Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils. J Leukoc Biol (2013) 1.11

Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models. J Allergy Clin Immunol (2003) 1.09

General intelligence in another primate: individual differences across cognitive task performance in a New World monkey (Saguinus oedipus). PLoS One (2009) 1.09

Validation of a new grading system for endoscopic examination of adenoid hypertrophy. Otolaryngol Head Neck Surg (2006) 1.08

Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. J Infect Dis (2007) 1.08

Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infect Immun (2004) 1.07

Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol (2013) 1.07

Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med (2010) 1.07

Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J Exp Med (2007) 1.06

Use of simulation to assess electronic health record safety in the intensive care unit: a pilot study. BMJ Open (2013) 1.04

Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res (2008) 1.04

Summary of the First International Gastrointestinal Eosinophil Research Symposium. J Pediatr Gastroenterol Nutr (2007) 1.03

Eosinophils preserve parasitic nematode larvae by regulating local immunity. J Immunol (2011) 1.03

Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis (2010) 1.01

Murine lung eosinophil activation and chemokine production in allergic airway inflammation. Cell Mol Immunol (2010) 1.01

Effect of proton pump inhibitor on esophageal eosinophilia. J Pediatr Gastroenterol Nutr (2013) 1.00

Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am J Respir Crit Care Med (2012) 1.00

Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb) (2007) 0.98

IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biol Ther (2007) 0.97

CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. Am J Pathol (2011) 0.95

Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J Leukoc Biol (2004) 0.95

Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis. Gut (2012) 0.94

Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun (2004) 0.93

Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis. J Innate Immun (2009) 0.92

Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury. Respir Res (2011) 0.92

Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis. Inflammation (2004) 0.91

Update on clinical and immunological features of eosinophilic gastrointestinal diseases. Curr Opin Gastroenterol (2011) 0.91

The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res (2011) 0.91

Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J Virol (2006) 0.91

A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol (2008) 0.91

High modulus nanopowder reinforced dimethacrylate matrix composites for dental cement applications. J Biomed Mater Res A (2007) 0.90

Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol (2009) 0.89

Eosinophils increase neuron branching in human and murine skin and in vitro. PLoS One (2011) 0.89

Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J Biol Chem (2008) 0.88

OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis. J Immunol (2010) 0.87

Muscle development and lineage-specific expression of CiMDF, the MyoD-family gene of Ciona intestinalis. Dev Biol (2002) 0.87

Why it is hard to find genes associated with social science traits: theoretical and empirical considerations. Am J Public Health (2013) 0.87

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer. Invest New Drugs (2006) 0.86

Eosinophils regulate peripheral B cell numbers in both mice and humans. J Immunol (2014) 0.86

Mast cells are required for full expression of allergen/SEB-induced skin inflammation. J Invest Dermatol (2013) 0.86

Subnasale flap for correction of columellar deformity. Plast Reconstr Surg (2007) 0.85

Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation. Am J Respir Cell Mol Biol (2013) 0.84

Racial variations in the incidence of severe alcohol withdrawal. J Med Toxicol (2009) 0.83

Signaling through Galphai2 protein is required for recruitment of neutrophils for antibody-mediated elimination of larval Strongyloides stercoralis in mice. J Leukoc Biol (2007) 0.83